Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 (St ...

United States Securities and Exchange Commission Washington, D. C. 20549 ________________________________________________ FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the fiscal year ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 (State or other jurisdiction of incorporation or organization) ...

STERIS plc (NYSE:STE) Q4 2021 Earnings Conference Call May 19, 2021 11:00 AM ET Company Participants Julie Winter - IR Mike Tokich - SVP and CFO Walt Rosebrough - President and CEO Dan Carestio - SVP and COO Conference Call Participants Dave Turkaly - JMP Securities Matthew Mishan - KeyBanc Capital Markets Mike Matson - Needham & Company Chris Cooley - Stephens Inc. Michael Polark - Robert W. Baird Operator Good morning, everyone and welcome to the STERIS plc Fourth Quarter 2021 Conference Call. All partici ...

Cantel Medical Corp. (CMD) Q2 2021 Earnings Conference Call March 9, 2021 8:30 AM ET Company Participants Ryan Lada - VP, Investor Relations George Fotiades - Chief Executive Officer Charles Diker - Chairman Shaun Blakeman - Senior Vice President and Chief Financial Officer Peter Clifford - President and Chief Operating Officer Seth Yellin - Executive Vice President, Strategy and Corporate Development Brian Capone - SVP, Corporate Controller and Chief Accounting Officer Conference Call Participants Matt Mis ...

NYSE:CM N 2nd Quarter FY21 Earnings Call March 09, 2021 Forward Looking Statements 2 This press release contains "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forwardlooking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, es ...

For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 353 1 232 2000 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ire ...

STERIS plc (NYSE:STE) Q3 2021 Earnings Conference Call February 3, 2021 10:00 AM ET Company Participants Julie Winter - Investor Relations Michael Tokich - Senior Vice President & Chief Financial Officer Walter Rosebrough - President & Chief Executive Officer Dan Carestio - Senior Vice President & Chief Operating Officer Conference Call Participants David Turkaly - JMP Securities Lawrence Keusch - Raymond James Christopher Cooley - Stephens Inc. Matthew Mishan - KeyBanc Capital Markets Michael Matson - Need ...

NYSE:CM N 1st Quarter FY21 Earnings Call December 8th, 2020 Forward Looking Statements 2 This press release contains "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forwardlooking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations ...

Cantel Medical Corp. (CMD) Q1 2021 Earnings Conference Call December 8, 2020 8:30 AM ET Company Participants Matt Micowski - VP, IR and Financial Planning and Analysis George Fotiades - CEO Chuck Diker - Chairman Shaun Blakeman - SVP and CFO Peter Clifford - EVP and COO Seth Yellin - EVP, Strategy and Corporate Development Brian Capone - SVP, Corporate Controller and Chief Accounting Officer Conference Call Participants Matt Mishan - KeyBanc Capital Markets Larry Keusch - Raymond James Mike Matson - Needham ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-145506 ...